|
|
|
| home > pmps > spring 2004 > pharmaceutical counterfeiting ?° predicting the future |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
It is always difficult to predict the future; were it easy I would make a living from sitting at home playing the lottery. However, if we cannot accurately predict what is around the corner then we can make educated assessments of what is likely to happen. Investigating counterfeit pharmaceuticals is very much an intelligence-based pursuit. In the intelligence world, the analysis of patterns of activity and the following of trends are powerful weapons. Long-term studies of activity and the accurate analysis of information gleaned can be of great value, particularly when planning strategies to combat such activity. These skills can be transferred to the commercial world and specifically in this case to the pharmaceutical industry. Thus we are able, theoretically at least, to gain an insight into the aims of the counterfeiter.
There are massive threats associated with pharmaceutical counterfeiting. It should be borne in mind that this is a truly global activity, which is in many cases life threatening. Statistics show that there is a gradual and constant increase in pharmaceutical counterfeiting, and recent events reveal that this activity is no longer confined to less developed countries. In the UK, Western Europe and the US we are fortunate in that we have responsible and reactive monitoring and regulatory agencies, which respond rapidly to all cases of illegal pharmaceuticals.
However, it is becoming more of a problem in the Western world and we cannot afford to become complacent. Less developed countries are not so fortunate in that they have no efficient methods of detecting counterfeit pharmaceuticals and the agencies responsible are under-funded or prone to corruption. It is ironic that the countries which are least capable of fighting this battle are those with the greatest problems. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
6th European Forum for Qualified Person for Pharmacovigilance (QPPV)
24-26 April 2012, London, UK
This event is for European qualified persons for pharmacovigilance; deputy qualified persons; senior pharmacovigilance regulators and inspectors; CROs and consultants providing QPPV services; and national responsible persons for pharmacovigilance.
More info >> |
|
 |
News and Press Releases |
 |
APTAR PHARMA’S PRESERVATIVE-FREE MULTIDOSE DISPENSER OSD CHOSEN FOR THE FIRST TIME FOR AN EYE CARE PRODUCT
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser (OSD) has found its first application for the treatment of dry eye with the launch of VISMED® MULTI. Aptar Pharma has worked closely with the Swiss-German based Eye Care specialist TRB Chemedica for improving patient safety, achieving dosing accuracy and maintaining product stability on the ophthalmic spray device.
More info >> |
|
|
